Premium
Frontispiece: Catalytic Asymmetric Synthesis of the anti‐COVID‐19 Drug Remdesivir
Author(s) -
Wang Mo,
Zhang Lu,
Huo Xiaohong,
Zhang Zhenfeng,
Yuan Qianjia,
Li Panpan,
Chen Jianzhong,
Zou Yashi,
Wu Zhengxing,
Zhang Wanbin
Publication year - 2020
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202084761
Subject(s) - catalysis , covid-19 , chemistry , enantioselective synthesis , nucleoside , combinatorial chemistry , stereochemistry , medicine , organic chemistry , disease , pathology , infectious disease (medical specialty)
Asymmetric Synthesis The first catalytic asymmetric synthesis of remdesivir by the coupling of the P‐racemic phosphoryl chloride with protected nucleoside GS441524 is described by W. Zhang et al. in their Communication on page 20814.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom